Usefulness of a Thyroglobulin Liquid Chromatography–Tandem Mass Spectrometry Assay for Evaluation of Suspected Heterophile Interference
Mayo Clinic representatives Brian Netzel, Stefan Grebe, M.D., Ph.D., and Alicia Algeciras-Schimnich, Ph.D. authored the article, “Usefulness of a Thyroglobulin Liquid Chromatography–Tandem Mass Spectrometry Assay for Evaluation of Suspected Heterophile Interference,” in the July issue of Clinical Chemistry to describe their study which determined whether Tg measurement by LC-MS/MS would allow accurate quantification in samples with suspected HAB interference.
Recent Stories for Research
As of Aug. 22, there have been over 2600 suspected or confirmed cases of Ebola hemorrhagic fever. Of these cases, two adult United States nationals were admitted to Emory University Hospital in Atlanta, GA during the first week of August 2014 for treatment. To discuss their treatment, doctors of Emory Hospital authored the article, “Laboratory Test Support for Ebola Patients Within a High-Containment Facility,” in American Society for Clinical Pathology’s Lab Medicine Journal.
A recent article in The New York Times reported on celiac disease, an autoimmune disorder of the gut triggered by the gluten proteins in wheat and other grains, and its connection to the human brain. Upon analysis of several cases, treating an autoimmune disease of the gut (by avoiding gluten) resolved what looked like a debilitating disorder of the brain.
Other Posts for Research
- Evaluating Histologic Features to Distinguish Phyllodes Tumor From Cellular Fibroadenoma on Core Needle Biopsy Specimens
- Piero Rinaldo, M.D., Ph.D., Big Data Presentation Considered Top Highlight at AACC 2014
- Coverage of Frozen Section Technology Highlights the Value of Pathology
- Analyzing the Performance of Lab-Developed, Commercial Assays
- Mayo Clinic Pathologists Decrease Need for Repeat Surgeries
- Verifying Reagent Lot Performance
- Managing Big Data
- Using Quality Assurance to Improve Outreach Patient Experience
- Novel BCR-ABL1 Fusion Identified by Targeted Next-Generation Sequencing in a Patient with an atypical Myeloproliferative Neoplasm
- Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum (NMO)